Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
Proposed “TRIPS” Waiver Is the WRONG Way To…
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), yesterday sent a letter to U.S. Trade Representative (USTR) Ambassador Katherine Tai sharing BIO perspectives regarding the proposed WTO “TRIPS waiver”…
Learn more
BIO Welcomes Collaboration With New HHS, USTR…
The Biotechnology Innovation Organization (BIO) welcomes the confirmations this week of Katherine Tai to the position of U.S. Trade Representative (USTR) and Xavier Becerra to lead the Department of Health and Human Services (HHS).  The United…
Learn more
New Mexico's Clean Fuel Standard Will Ignite…
Albuquerque, NM (March 11, 2021) — Today, the Biotechnology Innovation Organization (BIO) released the following statement applauding the passage of a clean fuel standard in New Mexico: “The passage of a clean fuel standard in New Mexico…
Learn more
All Press Releases
  • Show All
Search
Results
BIO Welcomes U.S. Involvement in COVAX, ACT Accelerator Programs
January 21, 2021
The Biden administration just announced its intent for the United States to join the COVAX vaccine facility, which aims to deliver COVID-19 vaccines to poor and under-developed countries. Dr. Michelle McMurry-Heath, president and CEO of the…
BIO and LCFC Support New Mexico Governor's Vision to Address Climate Change Through Clean Fuel Standard
January 21, 2021
Washington, D.C. (January 20, 2021) — The BiotechnologyInnovation Organization (BIO) and the Low Carbon Fuels Coalition (LCFC) today released the following statement in support of New Mexico Governor Michelle Lujan Grisham’s inclusion of a…
BIO Condemns Trump Administration's Last-ditch Effort To Strip Critical Medicare Part D Protections
January 20, 2021
In his last day in office, former President Donald Trump proposed a sweeping change to Medicare’s “Part D” drug benefit. Billed as a demonstration project through the Centers for Medicare and Medicaid Innovation (CMMI), this new policy would allow…
BIO Congratulates President Biden and Vice President Harris on "Historic Inauguration"
January 20, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO) made the following remarks after President Joe Biden and Vice President Kamala Harris were sworn into office:  “On behalf of the Biotechnology…
Biotechnology’s Leading Trade Group Restructures for the Future
January 19, 2021
Washington, DC –  The Biotechnology Innovation Organization (BIO), which announced its transition to a new CEO in June to Dr. Michelle McMurry-Heath, is announcing a new leadership team and organizational structure that promises to provide long…
BIO Applauds Incoming Administration's Decision Elevating Key White House Science Post to Cabinet-level Agency
January 16, 2021
President-elect Joe Biden announced on Friday a plan to make the White House Office of Science and Technology Policy a Cabinet-level agency. Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the…
Trump Administration Move to Issue RFS Waivers "Beyond Egregious"
January 12, 2021
Stephanie Batchelor, vice president of BIO's Industrial and Environmental Section, released the following statement in reaction to the Trump administration's move to issue Renewable Fuel Standard (RFS) waivers for the 2019 compliance year. “This…
BIO Releases Statement Concerning Future Political Giving
January 11, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on BIO's political contributions:   "As of today BIO will be pausing our political giving so we can…
BIO Statement on CMS' Approval of TennCare Medicaid Waiver
January 11, 2021
Dan Durham, Executive Vice President for Health Policy at the Biotechnology Innovation Organization, released the following statement regarding the recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve the Tennessee…
BIO's Dr. Michelle McMurry-Heath Responds to "Unconscionable" Attacks on U.S. Capitol
January 7, 2021
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization, made the following comments in response to today's violence at the United States Capitol: "Today we watched in horror as angry and unruly mobs attacked…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today